Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammatory Bowel Diseases | 16 | 2023 | 83 | 4.490 |
Why?
|
Crohn Disease | 9 | 2023 | 41 | 2.100 |
Why?
|
Colitis, Ulcerative | 9 | 2022 | 63 | 1.740 |
Why?
|
Gastrointestinal Microbiome | 9 | 2019 | 172 | 1.660 |
Why?
|
Intestinal Mucosa | 14 | 2019 | 184 | 1.480 |
Why?
|
Diet | 6 | 2019 | 170 | 1.270 |
Why?
|
Colon | 10 | 2019 | 137 | 1.170 |
Why?
|
Dietary Carbohydrates | 3 | 2020 | 10 | 1.150 |
Why?
|
Particulate Matter | 3 | 2018 | 16 | 1.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2019 | 186 | 1.040 |
Why?
|
Gastrointestinal Tract | 5 | 2018 | 52 | 1.010 |
Why?
|
Metagenome | 4 | 2015 | 17 | 0.810 |
Why?
|
Microbiota | 8 | 2018 | 91 | 0.770 |
Why?
|
Diverticulitis | 1 | 2021 | 2 | 0.760 |
Why?
|
Adiposity | 1 | 2021 | 38 | 0.760 |
Why?
|
Adipose Tissue | 1 | 2021 | 62 | 0.750 |
Why?
|
Humans | 51 | 2023 | 26260 | 0.730 |
Why?
|
Immunosuppressive Agents | 4 | 2019 | 124 | 0.690 |
Why?
|
Intestines | 4 | 2017 | 94 | 0.680 |
Why?
|
Colitis, Collagenous | 1 | 2019 | 2 | 0.640 |
Why?
|
Adult | 24 | 2023 | 7447 | 0.640 |
Why?
|
Inhalation Exposure | 2 | 2018 | 4 | 0.640 |
Why?
|
Eosinophilic Esophagitis | 1 | 2018 | 3 | 0.640 |
Why?
|
Liver Diseases, Alcoholic | 3 | 2017 | 39 | 0.640 |
Why?
|
Air Pollutants | 1 | 2018 | 7 | 0.620 |
Why?
|
RNA, Ribosomal, 16S | 4 | 2017 | 47 | 0.610 |
Why?
|
Bacteria | 6 | 2017 | 73 | 0.590 |
Why?
|
Antibodies, Monoclonal, Humanized | 2 | 2018 | 87 | 0.590 |
Why?
|
Complementary Therapies | 1 | 2017 | 7 | 0.590 |
Why?
|
ABO Blood-Group System | 1 | 2017 | 5 | 0.580 |
Why?
|
Female | 30 | 2023 | 14516 | 0.580 |
Why?
|
Middle Aged | 23 | 2023 | 8600 | 0.570 |
Why?
|
Male | 30 | 2021 | 14124 | 0.540 |
Why?
|
HIV Infections | 4 | 2018 | 460 | 0.540 |
Why?
|
Methane | 1 | 2016 | 2 | 0.540 |
Why?
|
Diverticulum | 1 | 2016 | 3 | 0.540 |
Why?
|
Ethanol | 3 | 2015 | 113 | 0.520 |
Why?
|
Anti-Inflammatory Agents | 3 | 2014 | 75 | 0.520 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2023 | 176 | 0.510 |
Why?
|
Feces | 10 | 2019 | 105 | 0.500 |
Why?
|
Hepatitis B Vaccines | 1 | 2014 | 3 | 0.480 |
Why?
|
Hepatitis B | 1 | 2014 | 13 | 0.480 |
Why?
|
Vaccination | 1 | 2014 | 29 | 0.480 |
Why?
|
Dietary Proteins | 3 | 2017 | 22 | 0.450 |
Why?
|
Practice Patterns, Physicians' | 1 | 2014 | 104 | 0.440 |
Why?
|
Capsule Endoscopy | 1 | 2012 | 2 | 0.420 |
Why?
|
Gastrointestinal Transit | 1 | 2012 | 10 | 0.420 |
Why?
|
Intestine, Small | 1 | 2012 | 28 | 0.410 |
Why?
|
Oxidants | 2 | 2011 | 31 | 0.390 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 51 | 0.390 |
Why?
|
Dysbiosis | 4 | 2015 | 55 | 0.380 |
Why?
|
Alcoholism | 1 | 2012 | 64 | 0.380 |
Why?
|
Cell Membrane Permeability | 1 | 2011 | 54 | 0.370 |
Why?
|
Breast Neoplasms | 1 | 2014 | 353 | 0.350 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2009 | 8 | 0.330 |
Why?
|
Dietary Fiber | 3 | 2020 | 20 | 0.330 |
Why?
|
Central Nervous System Depressants | 1 | 2009 | 18 | 0.330 |
Why?
|
Endotoxemia | 1 | 2009 | 24 | 0.330 |
Why?
|
Polymerase Chain Reaction | 4 | 2017 | 106 | 0.310 |
Why?
|
Starch | 2 | 2019 | 9 | 0.310 |
Why?
|
Animals | 9 | 2019 | 3391 | 0.300 |
Why?
|
Inflammation | 4 | 2018 | 265 | 0.300 |
Why?
|
Aged | 13 | 2019 | 8764 | 0.280 |
Why?
|
Quality of Life | 4 | 2020 | 621 | 0.280 |
Why?
|
Aspartate Aminotransferases | 1 | 2006 | 14 | 0.270 |
Why?
|
Alanine Transaminase | 1 | 2006 | 13 | 0.270 |
Why?
|
Serum Albumin | 1 | 2006 | 21 | 0.270 |
Why?
|
Colon, Sigmoid | 2 | 2017 | 17 | 0.260 |
Why?
|
Biopsy | 6 | 2018 | 200 | 0.260 |
Why?
|
Mice | 5 | 2018 | 1282 | 0.250 |
Why?
|
Air Pollution | 2 | 2018 | 11 | 0.250 |
Why?
|
Metabolome | 2 | 2015 | 16 | 0.240 |
Why?
|
Volatile Organic Compounds | 2 | 2015 | 10 | 0.230 |
Why?
|
Mice, Inbred C57BL | 4 | 2019 | 370 | 0.230 |
Why?
|
Logistic Models | 2 | 2016 | 365 | 0.220 |
Why?
|
Case-Control Studies | 5 | 2017 | 566 | 0.220 |
Why?
|
Remission Induction | 3 | 2020 | 89 | 0.210 |
Why?
|
Reactive Oxygen Species | 3 | 2011 | 111 | 0.210 |
Why?
|
Gastrointestinal Agents | 1 | 2002 | 12 | 0.200 |
Why?
|
alpha-Synuclein | 2 | 2015 | 121 | 0.200 |
Why?
|
Subcutaneous Fat | 1 | 2021 | 7 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 119 | 0.190 |
Why?
|
Absorptiometry, Photon | 1 | 2021 | 79 | 0.190 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 125 | 0.190 |
Why?
|
Retrospective Studies | 3 | 2016 | 3366 | 0.190 |
Why?
|
Celiac Disease | 2 | 2016 | 6 | 0.180 |
Why?
|
Dietary Fats | 2 | 2017 | 19 | 0.180 |
Why?
|
Phylogeny | 2 | 2017 | 46 | 0.180 |
Why?
|
Young Adult | 5 | 2019 | 1886 | 0.180 |
Why?
|
Adolescent | 3 | 2015 | 2079 | 0.170 |
Why?
|
Constipation | 2 | 2017 | 18 | 0.170 |
Why?
|
Ultrasonography | 1 | 2021 | 222 | 0.170 |
Why?
|
Irritable Bowel Syndrome | 1 | 2019 | 8 | 0.160 |
Why?
|
Firmicutes | 1 | 2019 | 6 | 0.160 |
Why?
|
Butyrates | 1 | 2019 | 22 | 0.160 |
Why?
|
Antioxidants | 3 | 2006 | 55 | 0.160 |
Why?
|
Mucous Membrane | 1 | 2019 | 29 | 0.160 |
Why?
|
Fatty Acids | 2 | 2019 | 36 | 0.160 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 51 | 0.160 |
Why?
|
Interferon Type I | 1 | 2018 | 11 | 0.160 |
Why?
|
Hospitalization | 2 | 2023 | 294 | 0.150 |
Why?
|
Ileum | 3 | 2017 | 15 | 0.150 |
Why?
|
Immunologic Factors | 1 | 2018 | 32 | 0.150 |
Why?
|
Prevalence | 2 | 2022 | 437 | 0.150 |
Why?
|
Micronutrients | 1 | 2017 | 3 | 0.150 |
Why?
|
Adaptation, Psychological | 2 | 2021 | 138 | 0.150 |
Why?
|
Vitamin D Deficiency | 1 | 2017 | 10 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 112 | 0.150 |
Why?
|
Food Additives | 1 | 2017 | 6 | 0.150 |
Why?
|
Wound Healing | 1 | 2019 | 149 | 0.150 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2017 | 11 | 0.150 |
Why?
|
Discriminant Analysis | 1 | 2017 | 7 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 44 | 0.150 |
Why?
|
Kupffer Cells | 1 | 2017 | 2 | 0.140 |
Why?
|
Defecation | 1 | 2017 | 4 | 0.140 |
Why?
|
NF-kappa B | 2 | 2011 | 108 | 0.140 |
Why?
|
Candida | 1 | 2017 | 11 | 0.140 |
Why?
|
Hepatocytes | 1 | 2017 | 8 | 0.140 |
Why?
|
Microspheres | 1 | 2017 | 22 | 0.140 |
Why?
|
Prebiotics | 1 | 2017 | 21 | 0.140 |
Why?
|
Enteral Nutrition | 1 | 2017 | 58 | 0.140 |
Why?
|
Demography | 1 | 2017 | 71 | 0.140 |
Why?
|
Sulfur-Reducing Bacteria | 1 | 2017 | 1 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2017 | 35 | 0.140 |
Why?
|
Biodiversity | 1 | 2017 | 35 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 374 | 0.140 |
Why?
|
Multiple System Atrophy | 1 | 2017 | 35 | 0.130 |
Why?
|
Breath Tests | 1 | 2016 | 10 | 0.130 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 236 | 0.130 |
Why?
|
Zonula Occludens-1 Protein | 2 | 2017 | 16 | 0.130 |
Why?
|
Colonoscopy | 1 | 2016 | 41 | 0.130 |
Why?
|
Adenocarcinoma | 1 | 2017 | 123 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 77 | 0.130 |
Why?
|
Risk Factors | 4 | 2021 | 2265 | 0.130 |
Why?
|
Nutrition Surveys | 1 | 2015 | 10 | 0.130 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 853 | 0.130 |
Why?
|
Biomarkers | 3 | 2014 | 556 | 0.130 |
Why?
|
Chicago | 2 | 2017 | 843 | 0.130 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 74 | 0.130 |
Why?
|
Rheumatic Diseases | 1 | 2016 | 54 | 0.120 |
Why?
|
Parkinson Disease | 2 | 2015 | 842 | 0.120 |
Why?
|
Caudovirales | 1 | 2015 | 2 | 0.120 |
Why?
|
Microviridae | 1 | 2015 | 2 | 0.120 |
Why?
|
Immunity, Mucosal | 1 | 2015 | 18 | 0.120 |
Why?
|
Permeability | 3 | 2014 | 116 | 0.120 |
Why?
|
Pattern Recognition, Automated | 1 | 2015 | 7 | 0.120 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2014 | 6 | 0.120 |
Why?
|
Serologic Tests | 1 | 2014 | 9 | 0.120 |
Why?
|
Particle Size | 2 | 2011 | 51 | 0.120 |
Why?
|
Carcinoembryonic Antigen | 1 | 2014 | 5 | 0.120 |
Why?
|
Dietary Supplements | 1 | 2014 | 55 | 0.120 |
Why?
|
Tertiary Care Centers | 1 | 2014 | 63 | 0.120 |
Why?
|
Adalimumab | 1 | 2014 | 16 | 0.120 |
Why?
|
Infant, Premature | 1 | 2016 | 201 | 0.120 |
Why?
|
Interleukin-6 | 2 | 2011 | 72 | 0.120 |
Why?
|
Mastectomy | 1 | 2014 | 21 | 0.120 |
Why?
|
Diarrhea | 1 | 2014 | 31 | 0.110 |
Why?
|
Referral and Consultation | 1 | 2014 | 78 | 0.110 |
Why?
|
Photoperiod | 1 | 2014 | 39 | 0.110 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 93 | 0.110 |
Why?
|
Hypertension | 1 | 2016 | 222 | 0.110 |
Why?
|
Solid Phase Microextraction | 1 | 2013 | 4 | 0.110 |
Why?
|
Mental Competency | 1 | 2013 | 9 | 0.110 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2016 | 189 | 0.110 |
Why?
|
Artifacts | 1 | 2013 | 33 | 0.110 |
Why?
|
Academic Medical Centers | 1 | 2014 | 126 | 0.110 |
Why?
|
Age Factors | 1 | 2016 | 751 | 0.110 |
Why?
|
Specimen Handling | 1 | 2013 | 40 | 0.110 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2016 | 177 | 0.110 |
Why?
|
Caco-2 Cells | 2 | 2011 | 55 | 0.110 |
Why?
|
Patient Participation | 1 | 2013 | 49 | 0.110 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 459 | 0.110 |
Why?
|
Cytokines | 3 | 2017 | 226 | 0.110 |
Why?
|
Fatty Acids, Volatile | 3 | 2019 | 34 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 186 | 0.100 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2012 | 16 | 0.100 |
Why?
|
Oxidative Stress | 2 | 2011 | 97 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 723 | 0.100 |
Why?
|
Enteric Nervous System | 1 | 2011 | 5 | 0.100 |
Why?
|
District of Columbia | 1 | 2011 | 3 | 0.100 |
Why?
|
Chronic Disease | 3 | 2022 | 419 | 0.100 |
Why?
|
Occludin | 1 | 2011 | 11 | 0.100 |
Why?
|
Electric Impedance | 1 | 2011 | 24 | 0.100 |
Why?
|
Tight Junctions | 1 | 2011 | 23 | 0.100 |
Why?
|
Cell Death | 1 | 2011 | 43 | 0.090 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2011 | 1 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2011 | 25 | 0.090 |
Why?
|
Child | 1 | 2015 | 1235 | 0.090 |
Why?
|
Blood Coagulation | 1 | 2011 | 17 | 0.090 |
Why?
|
Mitochondria | 1 | 2011 | 57 | 0.090 |
Why?
|
Circadian Rhythm | 1 | 2014 | 231 | 0.090 |
Why?
|
Inpatients | 1 | 2012 | 135 | 0.090 |
Why?
|
Pneumonia | 1 | 2011 | 70 | 0.090 |
Why?
|
Membrane Proteins | 1 | 2011 | 151 | 0.090 |
Why?
|
Peptide Mapping | 1 | 2009 | 5 | 0.080 |
Why?
|
Intestinal Absorption | 1 | 2009 | 35 | 0.080 |
Why?
|
Glucose | 1 | 2009 | 48 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 318 | 0.080 |
Why?
|
Neurons | 1 | 2011 | 312 | 0.080 |
Why?
|
Tyrosine | 2 | 2011 | 24 | 0.080 |
Why?
|
Rats | 1 | 2009 | 596 | 0.070 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2007 | 4 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 15 | 0.070 |
Why?
|
Pouchitis | 1 | 2007 | 2 | 0.070 |
Why?
|
Colonic Pouches | 1 | 2007 | 2 | 0.070 |
Why?
|
Proctocolectomy, Restorative | 1 | 2007 | 4 | 0.070 |
Why?
|
DNA, Bacterial | 2 | 2017 | 39 | 0.070 |
Why?
|
Plant Preparations | 1 | 2006 | 7 | 0.070 |
Why?
|
Phytotherapy | 1 | 2006 | 11 | 0.070 |
Why?
|
Physical Fitness | 1 | 2006 | 57 | 0.060 |
Why?
|
Health Status Disparities | 2 | 2017 | 71 | 0.060 |
Why?
|
Aged, 80 and over | 2 | 2012 | 4675 | 0.060 |
Why?
|
Esophagitis | 1 | 2003 | 6 | 0.060 |
Why?
|
Endoscopy, Digestive System | 1 | 2003 | 7 | 0.060 |
Why?
|
Eosinophilia | 1 | 2003 | 35 | 0.050 |
Why?
|
Colonic Diseases, Functional | 1 | 2003 | 3 | 0.050 |
Why?
|
Microtubules | 1 | 2003 | 28 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2003 | 28 | 0.050 |
Why?
|
Cytoskeleton | 1 | 2003 | 38 | 0.050 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 19 | 0.050 |
Why?
|
Recurrence | 2 | 2020 | 314 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2003 | 75 | 0.050 |
Why?
|
Gastrointestinal Diseases | 1 | 2003 | 35 | 0.050 |
Why?
|
Quinolones | 1 | 2002 | 12 | 0.050 |
Why?
|
Alanine | 1 | 2002 | 9 | 0.050 |
Why?
|
Digestive System | 1 | 2002 | 13 | 0.050 |
Why?
|
Respiratory Burst | 1 | 2002 | 27 | 0.050 |
Why?
|
Pancreatitis | 1 | 2002 | 19 | 0.050 |
Why?
|
Exercise | 1 | 2006 | 451 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2003 | 103 | 0.050 |
Why?
|
Neutrophils | 1 | 2002 | 96 | 0.050 |
Why?
|
Uncertainty | 1 | 2021 | 8 | 0.050 |
Why?
|
Proctitis | 1 | 2001 | 3 | 0.050 |
Why?
|
Genetic Therapy | 1 | 2002 | 80 | 0.050 |
Why?
|
Vitamin E | 1 | 2001 | 26 | 0.050 |
Why?
|
Ascorbic Acid | 1 | 2001 | 35 | 0.050 |
Why?
|
Radiation Injuries | 1 | 2001 | 26 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 192 | 0.050 |
Why?
|
Meat | 1 | 2020 | 1 | 0.040 |
Why?
|
Food, Organic | 1 | 2020 | 2 | 0.040 |
Why?
|
Time Factors | 2 | 2014 | 1382 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2020 | 13 | 0.040 |
Why?
|
Pandemics | 1 | 2022 | 238 | 0.040 |
Why?
|
Pain | 1 | 2023 | 389 | 0.040 |
Why?
|
Drug Resistance | 1 | 2019 | 42 | 0.040 |
Why?
|
Steroids | 1 | 2019 | 23 | 0.040 |
Why?
|
Solanum tuberosum | 1 | 2019 | 3 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2002 | 339 | 0.040 |
Why?
|
Societies, Medical | 1 | 2020 | 146 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 54 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 311 | 0.040 |
Why?
|
Anxiety | 1 | 2019 | 136 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 294 | 0.040 |
Why?
|
DNA, Ribosomal | 1 | 2017 | 5 | 0.040 |
Why?
|
Patient Reported Outcome Measures | 1 | 2022 | 495 | 0.040 |
Why?
|
DNA, Viral | 1 | 2017 | 36 | 0.040 |
Why?
|
Viral Load | 1 | 2017 | 72 | 0.040 |
Why?
|
Fermentation | 1 | 2017 | 11 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2017 | 47 | 0.040 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2017 | 33 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2017 | 33 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2017 | 264 | 0.030 |
Why?
|
Sigmoidoscopy | 1 | 2016 | 7 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2017 | 400 | 0.030 |
Why?
|
Cohort Studies | 2 | 2015 | 1838 | 0.030 |
Why?
|
Birth Weight | 1 | 2016 | 43 | 0.030 |
Why?
|
Gestational Age | 1 | 2016 | 79 | 0.030 |
Why?
|
Employment | 1 | 2016 | 40 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 102 | 0.030 |
Why?
|
Income | 1 | 2016 | 72 | 0.030 |
Why?
|
Protein Folding | 1 | 2015 | 18 | 0.030 |
Why?
|
Alkanes | 1 | 2015 | 3 | 0.030 |
Why?
|
Sesquiterpenes | 1 | 2015 | 4 | 0.030 |
Why?
|
Terpenes | 1 | 2015 | 4 | 0.030 |
Why?
|
Sulfides | 1 | 2015 | 10 | 0.030 |
Why?
|
Fatty Alcohols | 1 | 2015 | 7 | 0.030 |
Why?
|
Disulfides | 1 | 2015 | 9 | 0.030 |
Why?
|
Support Vector Machine | 1 | 2015 | 5 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 290 | 0.030 |
Why?
|
Metabolomics | 1 | 2014 | 17 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2014 | 14 | 0.030 |
Why?
|
Bacterial Translocation | 1 | 2014 | 22 | 0.030 |
Why?
|
Lactobacillus | 1 | 2014 | 17 | 0.030 |
Why?
|
Dietary Sucrose | 1 | 2014 | 7 | 0.030 |
Why?
|
Diet, High-Fat | 1 | 2014 | 10 | 0.030 |
Why?
|
Educational Status | 1 | 2016 | 288 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2016 | 209 | 0.030 |
Why?
|
Infant | 1 | 2016 | 520 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2013 | 13 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2013 | 26 | 0.030 |
Why?
|
Light | 1 | 2014 | 60 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2016 | 593 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 485 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2015 | 677 | 0.030 |
Why?
|
Social Support | 1 | 2013 | 182 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 363 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2016 | 1343 | 0.020 |
Why?
|
Prospective Studies | 1 | 2017 | 1668 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2014 | 570 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2013 | 212 | 0.020 |
Why?
|
Adipose Tissue, White | 1 | 2011 | 2 | 0.020 |
Why?
|
Fibrin | 1 | 2011 | 4 | 0.020 |
Why?
|
Cities | 1 | 2011 | 16 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2011 | 91 | 0.020 |
Why?
|
Substantia Nigra | 1 | 2011 | 113 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2007 | 1738 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 231 | 0.020 |
Why?
|
Lung | 1 | 2011 | 155 | 0.020 |
Why?
|
Depression | 1 | 2013 | 407 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2013 | 1074 | 0.020 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2007 | 5 | 0.020 |
Why?
|
Biofilms | 1 | 2007 | 14 | 0.020 |
Why?
|
Herbal Medicine | 1 | 2006 | 2 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2007 | 97 | 0.020 |
Why?
|
Reference Values | 1 | 2007 | 184 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2007 | 337 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2006 | 49 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 215 | 0.020 |
Why?
|
Asthma | 1 | 2006 | 109 | 0.020 |
Why?
|
Risk Assessment | 1 | 2007 | 629 | 0.010 |
Why?
|
Histamine H1 Antagonists | 1 | 2003 | 2 | 0.010 |
Why?
|
Budesonide | 1 | 2003 | 3 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 2003 | 4 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2003 | 10 | 0.010 |
Why?
|
Azathioprine | 1 | 2003 | 8 | 0.010 |
Why?
|
Histamine H2 Antagonists | 1 | 2003 | 7 | 0.010 |
Why?
|
Esophageal Perforation | 1 | 2003 | 7 | 0.010 |
Why?
|
Proton Pump Inhibitors | 1 | 2003 | 11 | 0.010 |
Why?
|
Gastrointestinal Motility | 1 | 2003 | 11 | 0.010 |
Why?
|
Proton Pumps | 1 | 2003 | 12 | 0.010 |
Why?
|
Catheterization | 1 | 2003 | 41 | 0.010 |
Why?
|
Gastroesophageal Reflux | 1 | 2003 | 25 | 0.010 |
Why?
|
Deglutition Disorders | 1 | 2003 | 35 | 0.010 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2003 | 8 | 0.010 |
Why?
|
Cytoprotection | 1 | 2003 | 9 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 39 | 0.010 |
Why?
|
Drug Interactions | 1 | 2003 | 35 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2003 | 12 | 0.010 |
Why?
|
Prednisone | 1 | 2003 | 61 | 0.010 |
Why?
|
Free Radicals | 1 | 2003 | 8 | 0.010 |
Why?
|
Luminescent Measurements | 1 | 2003 | 20 | 0.010 |
Why?
|
Tubulin | 1 | 2003 | 17 | 0.010 |
Why?
|
Eosinophils | 1 | 2003 | 42 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 104 | 0.010 |
Why?
|
Immunoblotting | 1 | 2003 | 55 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2006 | 252 | 0.010 |
Why?
|
Actins | 1 | 2003 | 35 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2003 | 62 | 0.010 |
Why?
|
Esophagus | 1 | 2003 | 62 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 133 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 347 | 0.010 |
Why?
|
Gastric Acid | 1 | 2002 | 8 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2002 | 128 | 0.010 |
Why?
|
Food Hypersensitivity | 1 | 2002 | 39 | 0.010 |
Why?
|
Liver Diseases | 1 | 2002 | 31 | 0.010 |
Why?
|
Acute Disease | 1 | 2002 | 192 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2001 | 170 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2003 | 3390 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2006 | 2062 | 0.010 |
Why?
|